NIR-Guided Sentinel Lymph Node Mapping in Melanoma

NCT01121718 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: ICG Intervention

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]